Latest Opdivo news
AAAAI: No Increase Seen in Asthma Exacerbations With ICI Use for Melanoma, Renal Cell Carcinoma
posted March 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Recurrence-Free Survival Longer With Nivolumab Than Ipilimumab in Melanoma
posted October 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance
posted June 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
posted February 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors 
AMH Predicts Benefit of Chemo + Endocrine Therapy in Under 55s With Breast Cancer 
Entinostat + Nivolumab Yields Durable Results in Some Pancreatic Cancer Patients 
Nivolumab Combo Treats Advanced Esophageal Squamous-Cell Carcinoma 
Adjuvant Nivolumab Slows Muscle-Invasive Urothelial Carcinoma 
CDC: 2013 to 2018 Saw Jump in Drug OD Deaths Involving Cocaine Monthly Specialist Briefings
Stay Connected
